Health CanadaGeneral Alert
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Tre...
Published: January 17, 2023Recall ID: 72590Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information - Product safety - COVID
Product Description & Identification
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
Affected Products
EVUSHELD (tixagevimab and cilgavimab for injection)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 72590 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/evusheld-tixagevimab-and-cilgavimab-injection-risk-prophylaxis-or-treatment-failure-0 |
| Issue | New safety information - Product safety - COVID |
| Title | EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants |
| Product | EVUSHELD (tixagevimab and cilgavimab for injection) |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2023-01-17 |
| Organization | Marketed health products |